Autopsy report · NCT03530254

Clinical Study of PGT-A Versus PGT-A+ERA

“Low recruitment speed, higher percentage drop-out and SARS-CoV-2 pandemic situation”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 9 months before it stopped.
• 368 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Igenomix

Sponsor type

Industry

Conditions

Infertility of Uterine Origin

Interventions

PGT-A; ERA Test

Participants

368

Sites

15

Countries

Argentina, Brazil, Canada, Chile, Georgia, India, Mexico, Spain, Taiwan, Turkey (Türkiye), United States, Vietnam

Trials that died the same way

• Respiratory Muscle Training in Stroke Swallowing Disorders
  “Because of the SARS-COV2 pandemic. Recruitment stopped at 48 patients” (78% match in meaning)
• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (74% match in meaning)
• Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis
  “Recruitment slow due to COVID-19” (73% match in meaning)
• Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin
  “insufficient recruitment due to the pandemic situation” (73% match in meaning)
• Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery
  “COVID-19 pandemic impacted recruitment” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.